Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer

NCT00777335 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Very low recruitement rate.

Conditions

Breast Cancer

Interventions

DRUG: Panobinostat - LBH589
DRUG: Panobinostat - LBH589

Sponsor

Translational Research in Oncology